TNA
YDESW

True North Advisors’s YD Bio Ltd Warrants YDESW Stock Holding History

True North Advisors’s Portfolio YDESW Stock Details YDESW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$144K Sell
220,819
-200
-0.1% -$170 0.02% 245
2025
Q4 		$219K Buy
221,019
+1,999
+0.9% +$2.82K 0.03% 239
2025
Q3 		$467K Buy
+219,020
New +$382K 0.07% 137

Other funds holding YDESW

CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $9.2B AUM 23.26% 1-Year Est. Return
SSG
Summit Securities Group New York $810M AUM 27.35% 1-Year Est. Return

True North Advisors's YDESW Position: Q1 2026 in Review

True North Advisors reduced its YD Bio Ltd Warrants (YDESW) stake by 0.09% in Q1 2026, selling an estimated $170 and leaving 220,819 shares worth $144K. The position accounts for 0.02% of the portfolio, ranked #245.

True North Advisors first reported a position in YDESW in Q3 2025 and has held it in 3 quarters since. The position peaked at $467K in Q3 2025. 9 funds tracked by Wall St. Rank hold YDESW as of Q1 2026.

  • True North Advisors held 220,819 shares of YD Bio Ltd Warrants worth $144K as of Q1 2026.
  • True North Advisors sold 200 YD Bio Ltd Warrants shares in Q1 2026, an estimated $170.
  • YD Bio Ltd Warrants made up 0.02% of True North Advisors's portfolio in Q1 2026, its #245 holding.
  • True North Advisors first reported a position in YD Bio Ltd Warrants in Q3 2025 and has held it in 3 quarters since.
  • True North Advisors's YD Bio Ltd Warrants position peaked at $467K in Q3 2025.
  • 9 funds tracked by Wall St. Rank held YD Bio Ltd Warrants as of Q1 2026.

Based on True North Advisors's 13F filing for Q1 2026, filed 7 May 2026.